Intercure Ltd Stock Forecast, Predictions & Price Target

Analyst price target for INCR

Based on 2 analysts offering 12 month price targets for Intercure Ltd.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell INCR stock?

Based on 2 analysts offering ratings for Intercure Ltd.
Strong Buy
Strong Buy
2 analysts 100%
0 analysts 0%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INCR stock forecasts and price targets.

INCR vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
INCR$3.75$11.50+206.67%Strong Buy
TKNO$6.04$15.00+148.34%Strong Buy
DRRX$6.57$5.33-18.83%Strong Buy
OPTN$1.78$5.00+180.90%Strong Buy
ASRT$4.01$6.50+62.09%Strong Buy

Intercure Stock Forecast FAQ

Is Intercure Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: INCR) stock is to Strong Buy INCR stock.

Out of 2 analysts, 2 (100%) are recommending INCR as a Strong Buy, 0 (0%) are recommending INCR as a Buy, 0 (0%) are recommending INCR as a Hold, 0 (0%) are recommending INCR as a Sell, and 0 (0%) are recommending INCR as a Strong Sell.

If you're new to stock investing, here's how to buy Intercure stock.

What is INCR's Price Target?

According to 2 Wall Street analysts that have issued a 1 year INCR price target, the average INCR price target is $11.50, with the highest INCR stock price forecast at $13.00 and the lowest INCR stock price forecast at $10.00.

On average, Wall Street analysts predict that Intercure's share price could reach $11.50 by May 18, 2023. The average Intercure stock price prediction forecasts a potential upside of 206.67% from the current INCR share price of $3.75.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.